A randomized, double-blind, crossover study to evaluate the duration of erection following vardenafil (10mg) administration for four weeks in a fixed dose regimen compared to placebo in males with ED [erectile dysfunction]

Trial Profile

A randomized, double-blind, crossover study to evaluate the duration of erection following vardenafil (10mg) administration for four weeks in a fixed dose regimen compared to placebo in males with ED [erectile dysfunction]

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jan 2015

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms ENDURANCE
  • Sponsors Bayer
  • Most Recent Events

    • 19 Mar 2009 Results data presented at the European Association of Urology congress held in Stockholm, Sweden, in March 2009, as reported in a media release from Bayer-Schering Pharma.
    • 01 Jan 2009 Results have been published in The International Journla of Clinical Practice.
    • 20 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top